Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions

Author's Avatar
Oct 25, 2022

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International (‘CCI’), a Novo wholly-owned subsidiary, today announced the signing of a Sales and Consulting Agreement (the “Agreement”), which includes revenue-sharing potential, with Tranquility+Lifestyle+Solutions%2C+Inc. (‘TLS’), a company that has developed a technology platform to add a new dimension to both senior wellness and senior wellbeing, alongside keeping family members or care associates fully informed of detected abnormalities within an extremely responsive time frame, which is complimentary to Novo’s holistic approach to patient-first health and wellness.